EPHB2
- 1 lab in 1 country
- Animals1
- Cells1
Interventions
1Saikosaponin d
mediatesin human cells1downin human cells1
1 study
Saikosaponin d
mediatesin human cells1downin human cells1
Saikosaponin d mediates EPHB2 in human cells.
“Crucially, overexpressing EPHB2 abolished all the protective effects of SSD.”
Cellsfor protective effects of SSD in OX-LDL-treated hVSMCs
Clinical and experimental pharmacology & physiology1 Jun 2026
Saikosaponin d inhibits EPHB2 in human cells.
“Molecular studies confirmed that SSD directly binds to EPHB2 and downregulates its expression.”
Cells
Clinical and experimental pharmacology & physiology1 Jun 2026
Latest
2 in 12 monthsClinical and Experimental Pharmacology & Physiology
Saikosaponin D Alleviates Atherosclerosis by Regulating Autophagy and Senescence of VSMCs via Inhibiting EPHB2
Experiments in human cellsAtherosclerosis
Cellular & Molecular Biology Letters
Cognitive-exercise dual-task training delays natural aging/D-galactose-induced cognitive decline in mice
Experiments in miceCognitive decline